1) advanced small cell lung cancer (SCLC)
晚期小细胞肺癌
1.
Objective To observe the efficacy and safety of chemotherapy consisted of lobaplatin (LBP) combined with etoposide for patients with advanced small cell lung cancer (SCLC).
目的观察评价新一代铂类抗癌药物洛铂(LBP)联合足叶乙甙(VP-16)组成的LE方案治疗晚期小细胞肺癌(SCLC)的有效性和安全性。
2) advanced non-small cell lung cancer(NSCLC) and advanced small cell lung cancer(SCLC)
晚期非小细胞肺癌和晚期小细胞肺癌
3) Non-small cell lung cancer
晚期非小细胞肺癌
1.
Effect of pinxiao capsule with chemotherapy in treating non-small cell lung cancer;
平消胶囊配合化疗治疗晚期非小细胞肺癌疗效观察
2.
Objectives: To detect the serum levels of CEA, CYFRA21-1 and CA125 in patients with advanced non-small cell lung cancer before and after chemotherapy.
目的：通过检测晚期非小细胞肺癌患者化疗前后，血清癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)以及糖原抗原125(CA125)的水平变化，了解非小细胞肺癌患者化疗前后血清CEA、CYFRA21-1及CA125的水平变化与近期疗效及预后的相关关系。
3.
ObjectiveTo observe the effect of Jin Fu An Decoction in improving quality of life of patients with non-small cell lung cancer(NSCLC) inⅢorⅣstage.
目的观察金福安汤对中晚期非小细胞肺癌(NSCLC)患者生存质量、精神心理状态的作用。
4) elder advanced non-small cell lung cancer
老年晚期非小细胞肺癌
1.
Objective To observe the clinical effect of sequential chemotherapy of carboplatin and vinorelbine plus medicinal herbs in treatment of elder advanced non-small cell lung cancer and the effect on quality of life during the treatment.
目的研究老年晚期非小细胞肺癌经卡铂与诺维苯4周期两药序贯化疗加中草药治疗的疗效及安全性。
5) advanced non-small-cell lung cancer
晚期非小细胞肺癌
1.
Mitomycin, Vinorelbine plus Cisplatin in the treatment of 42 cases with advanced non-small-cell lung cancer.;
MNP方案治疗晚期非小细胞肺癌42例临床观察
2.
Gemcitabine and carboplatin combination chemotherapy for 27 cases of advanced non-small-cell lung cancer;
吉西他滨加卡铂治疗晚期非小细胞肺癌
3.
Clinical analysis on combined docetaxel and cisplatin for advanced non-small-cell lung cancer in 37 cases;
多西紫杉醇联合顺铂治疗37例晚期非小细胞肺癌临床分析
6) Advanced NSCLC
晚期非小细胞肺癌
1.
Methods: Sixty four patients aged 65~84 with advanced NSCLC received docetaxel 25 mg/m~2 weekly for 6 consecutive weeks, followed by 2 weeks without treatment.
方法:对1999年11月至2005年2月我院收治的64例年龄在65至84岁的老年晚期非小细胞肺癌患者,应用单药泰素帝每周用药剂量为25mg/m2化疗,连续6周,休息2周,评价疗效和毒性反应。
2.
Methods: In the clinical observation, 112 advanced NSCLC patients were randomly allocated into three groups, they are chemotherapy, chemotherapy plus Feiji capsule and Feiji capsule alone.
目的:观察中药肺积胶囊治疗晚期非小细胞肺癌(NSCLC)的近期疗效以及该制剂对实验肿瘤的抑瘤、抗转移作用。
补充资料：晚期智人
见智人、克罗马农人。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条